Literature DB >> 19897493

Cycling the wagons for biliverdin reductase.

Thomas W Sedlak, Solomon H Snyder.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19897493      PMCID： PMC2786007          DOI： 10.1074/jbc.L109.037119

Source DB:  PubMed          Journal:  J Biol Chem        ISSN： 0021-9258            Impact factor:   5.157


× No keyword cloud information.
  5 in total

Review 1.  Bilirubin benefits: cellular protection by a biliverdin reductase antioxidant cycle.

Authors:  Thomas W Sedlak; Solomon H Snyder
Journal:  Pediatrics       Date:  2004-06       Impact factor: 7.124

2.  Biliverdin reductase: a major physiologic cytoprotectant.

Authors:  David E Baranano; Mahil Rao; Christopher D Ferris; Solomon H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-27       Impact factor: 11.205

3.  Small interference RNA-mediated gene silencing of human biliverdin reductase, but not that of heme oxygenase-1, attenuates arsenite-mediated induction of the oxygenase and increases apoptosis in 293A kidney cells.

Authors:  Tihomir Miralem; Zhenbo Hu; Michael D Torno; Katherine M Lelli; Mahin D Maines
Journal:  J Biol Chem       Date:  2005-02-28       Impact factor: 5.157

4.  Bilirubin and glutathione have complementary antioxidant and cytoprotective roles.

Authors:  Thomas W Sedlak; Masoumeh Saleh; Daniel S Higginson; Bindu D Paul; Krishna R Juluri; Solomon H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-13       Impact factor: 11.205

5.  Limited role for the bilirubin-biliverdin redox amplification cycle in the cellular antioxidant protection by biliverdin reductase.

Authors:  Ghassan J Maghzal; Meng-Choo Leck; Emma Collinson; Cheng Li; Roland Stocker
Journal:  J Biol Chem       Date:  2009-08-18       Impact factor: 5.157
  5 in total
  6 in total

1.  Interaction of human biliverdin reductase with Akt/protein kinase B and phosphatidylinositol-dependent kinase 1 regulates glycogen synthase kinase 3 activity: a novel mechanism of Akt activation.

Authors:  Tihomir Miralem; Nicole Lerner-Marmarosh; Peter E M Gibbs; Jermaine L Jenkins; Chelsea Heimiller; Mahin D Maines
Journal:  FASEB J       Date:  2016-05-10       Impact factor: 5.191

2.  Bile pigments in pulmonary and vascular disease.

Authors:  Stefan W Ryter
Journal:  Front Pharmacol       Date:  2012-03-08       Impact factor: 5.810

3.  Direct Antioxidant Properties of Bilirubin and Biliverdin. Is there a Role for Biliverdin Reductase?

Authors:  Thomas Jansen; Andreas Daiber
Journal:  Front Pharmacol       Date:  2012-03-16       Impact factor: 5.810

Review 4.  Biliverdin reductase: a target for cancer therapy?

Authors:  Peter E M Gibbs; Tihomir Miralem; Mahin D Maines
Journal:  Front Pharmacol       Date:  2015-06-03       Impact factor: 5.810

5.  Scalable production of biliverdin IXα by Escherichia coli.

Authors:  Dong Chen; Jason D Brown; Yukie Kawasaki; Jerry Bommer; Jon Y Takemoto
Journal:  BMC Biotechnol       Date:  2012-11-23       Impact factor: 2.563

6.  Relationship between elevated bilirubin level and subclinical atherosclerosis as well as oxidative stress in Gilbert syndrome.

Authors:  Busra Copur; Nisbet Yilmaz; Canan Topcuoglu; Emrullah Kiziltunc; Mustafa Cetin; Turan Turhan; Burak Furkan Demir; Emin Altiparmak; Ihsan Ates
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2020
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.